Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIVANTI

Financiado

Cerrado

THE DIVIDING CELL MEMBRANE A PROMISING TARGET FOR NOVEL ANTIBIOTICS

"The world wide rise in multidrug resistant pathogens is a major healthcare problem, and both the World Health Organization and European Union have identified antimicrobial resistance as a public health priority. The number of nov... ver más

31/07/2017

UvA

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

UNIVERSITEIT VAN AMSTERDAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UvA

0.00€ | Lider

Proyectos interesantes

NAfrAM

Medical Technol...

Biotechnology

190K€ Cerrado

PID2020-113521RB-I00

Medical Technol...

Biotechnology

278K€ Cerrado

GNA NOW

Medical Technol...

Pharmaceuticals

22M€ Cerrado

BFU2017-90030-P

Medical Technol...

Microbiology

387K€ Cerrado

ENABLE

Medical Technol...

Pharmaceutical...

101M€ Cerrado

PATRES

Medical Technol...

Pharmaceuticals

164K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITEIT VAN AMSTERDAM No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "The world wide rise in multidrug resistant pathogens is a major healthcare problem, and both the World Health Organization and European Union have identified antimicrobial resistance as a public health priority. The number of novel antibiotics that enter the clinic has dwindled over the last decades, and the development of new antibiotics is urgent. Cell division is a logical antimicrobial drug target, yet there are currently no clinically approved compounds that target this process. One of the main reasons is that bacterial cell division, and especially the role of the cell membrane in this process, is poorly understood. Moreover, cell division is a robust process, and many potential lead compounds are likely to be missed in drug screens. The aim of my research is to elucidate molecular mechanisms of cell division, and to use this knowledge to support the development of novel antimicrobial compounds. I have made several discoveries that provide an excellent basis to pursue these objectives: (i) the discovery of an important cell division protein, (ii) the discovery that the membrane potential is involved in cell division, and (iii) the discovery that membrane curvature can function as a cue for protein localization. My research project will be (1) focused on the interplay between cell division proteins and the cell membrane, and (2) aimed at supporting the search for new antimicrobials. I will develop novel functional assays to detect cell division inhibitors, and I will develop assays to find compounds that kill non-growing cells. In addition, I will set up state-of-the-art bacterial cell biology assays to study, in real time, the effects of antimicrobials at the cellular level. This research will not only support the Biopharma industry in their search for next generation antibiotics but may also result in new food-grade antimicrobials for the Food industry."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores